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Abstract 
Background. ALK immunohistochemical staining (IHC) on formalin fixed paraffin 
embedded tissue or cellblock (CB) has been reported as an effective alternative of 
fluorescence hybridization in situ (FISH) in the detection of ALK gene rearrangement. 
However, CBs frequently lack adequate cellularity even when the direct smears are 
cellular. This study is aimed to assess the utility of ALK immunocytochemical staining 
(ICC) on direct smears using the cell transfer (CT) technique in the detection of ALK 
rearrangement.  
Methods. Fine needle aspiration (FNA) cases of lung adenocarcinoma in which ALK 
status had been determined by FISH on CB or concurrent biopsy were identified. ICC 
staining for ALK was performed on alcohol-fixed Papanicolaou-stained direct smears 
using the CT technique. ALK immunoreactivity was evaluated in a modified 
semiquantitative scale. Results were compared with those of FISH.  
Results: A total of 47 FNA specimens were included. Five of 7 FISH positive cases 
showed positive ALK ICC staining (71.4%) and 39 of 40 FISH negative cases were 
negative on ALK ICC staining (97.5%). The overall correlation between ALK ICC and 
FISH was 93.6%.  
Conclusion: ICC performed on the FNA smears using the CT technique is an alternative 
method for assessment of ALK rearrangement, especially when cellblock lacks adequate 
cellularity. 
 
 3 
Introduction 
Anaplastic lymphoma kinase (ALK) gene rearrangements represent the primary 
oncogenic driver in 3-5% of patients with non-small cell lung cancers (NSCLCs) 
especially adenocarcinomas, with echinoderm microtubule-associated protein-like 4 
(EML4) gene being the most frequent translocation partner1, 2. ALK inhibitor crizotinib 
has been associated with over 60% response rate in ALK-rearranged advanced NSCLCs3, 
4, as shown by multi-center clinical trials. ALK status is now a required study for 
NSCLCs, recommended by multiple societies including the College of American 
Pathologists (CAP)5. In previous clinical trials, ALK status was determined by 
fluorescence in situ hybridization (FISH) using the Vysis break-apart probe set (Abbott 
Molecular, Des Plaines, Ill), which to date is the only diagnostic assay licensed for this 
purpose by the US Food and Drug Administration (FDA) 6.  
The main advantage of the FISH method is the possibility of detecting all types of ALK 
rearrangements known to date. However, specialized techniques and training are required 
for the implementation and interpretation of ALK FISH testing.  Significant inter-
observer variability was shown even in the hands of experienced specialists7. 
Additionally, FISH as a screening assay is relatively expensive for most clinical settings. 
In contrast, immunohistochemistry (IHC) is relatively inexpensive, fast, and familiar to 
most pathologists. Zhou et al8 studied ALK IHC on 410 resected lung adenocarcinomas 
and compared the results to corresponding FISH assays. They found that all 333 IHC 
negative cases were negative by FISH, and all 28 FISH positive cases were positive on 
IHC. A similar study using 465 resected NSCLCs by Paik et al9 also showed that the 
sensitivity and specificity of IHC compared to FISH was 100% and 95.8%, respectively. 
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CAP guidelines recommend using a sensitive ALK IHC as screening test for ALK 
rearrangement on formalin-fixed paraffin-embedded (FFPE) tissue5.  
With the advance of imaging-assisted biopsy techniques and fine-needle aspiration 
(FNA) cytology, the pathological diagnosis of lung cancer is more commonly done 
preoperatively on FNA material. The ALK FISH and IHC protocols used for FFPE tissue 
specimens can be used on cell blocks (CB) for immunocytochemistry (ICC) assays. 
However, although we perform rapid on-site evaluations on all FNAs performed at our 
institution and typically collect multiple dedicated passes for CB in lung cancer patients, 
the CBs still sometimes lack adequate cellularity for ALK testing even when the direct 
smears are cellular. As an alternative approach, if conventional CBs lack adequate 
cellularity, ICC can be performed on cell-transferred (CT) direct smears and multiple 
immunostains can be applied to a single direct smear using this technique10-13. The aim of 
this study is to assess the reliability of the cell transfer (CT) technique for the 
immunocytochemical assessment of ALK status of aspirates of primary and metastatic 
lung adenocarcinomas. 
Materials and Methods 
This study was approved by the Institutional Review Board of Indiana University. A 
computerized search of the cytopathology and surgical pathology archives was 
performed. FNA cases diagnosed as primary or metastatic lung adenocarcinoma in which 
ALK status had been previously evaluated by FISH on a CB or concurrent surgical 
biopsy were identified over a period of 33 months (September 2011 through May 2014). 
The search yielded a total of 47 FNA specimens including FNAs from 26 primary lung 
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lesions and 21 metastatic lesions (lymph node 15, bone 2, liver 2, chest wall 1, and 
adrenal gland 1). Of these, formalin-fixed core biopsies were used for FISH in 8 cases 
and formalin-fixed CBs were used in 39 FNA cases.  
The ethanol-fixed, Papanicolaou-stained direct smears from each case were reviewed, 
and the most cellular slide was chosen for CT. CT technique was performed as described 
previously13. Briefly, after the removal of coverslip using xylene, a thin layer of Mount-
Quick media (Daido Sangyo Co Ltd, Japan) was spread uniformly over the wet slide to 
entirely cover the cellular material. The slide was then placed in a 60°C heated oven for 3 
hours or more until the media hardened. The cellular areas (at least 200 tumor cells) to be 
transferred were then marked using a permanent marker. After incubating in a 50°C water 
bath for 2 hours, the mounting media with the embedded cells was slowly peeled off the 
slide using forceps and a scalpel. The marked area was cut off and placed on a charged 
glass slide. The slide was dried in a 60°C oven for at least 2 hours. The dried slide was 
washed in four exchanges of xylene (15 min each) to remove the mounting media, and 
then was rehydrated with two exchanges of absolute alcohol, two exchanges of 95% 
alcohol, and two exchanges of deionized water (15 min each). The slide was stored in 
deionized water until ICC was performed.  
ICC for ALK was performed on the cell-transfer slides using primary rabbit monoclonal 
anti-ALK antibody D5F3 (Cell Signaling Technology, Billerica, MA) with Dako 
EnVision detection kit. No modifications were made in the immune-staining process on 
the cell-transferred slides compared with formalin-fixed tissue. The results were scored 
by two independent observers (C.Z. and H.H.W.) using a modified semi-quantitative 
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graded criteria described previously 8 (Table 1). ICC results were excluded from the 
study if the CT slide contained less than 200 cells. ICC results were compared with those 
of FISH performed on the correlating CB or core biopsy. 
Results 
The results of the ICC on the CT smears and results of FISH on correlating formalin-
fixed CB or core biopsy were summarized in Table 2. 
All 47 FNA specimens were adequately cellular for evaluation. The correlating FISH 
studies showed that 40 were negative and 7 were positive for ALK rearrangement.  
Five of 7 FISH positive cases (71.4%) showed positive ALK ICC staining, with 4 cases 
showing 3+ staining (Figure 1) and one case showing 2+ staining. Two FISH positive 
cases were negative on ICC (score 1+, Figure 2), and the concurrent core biopsy and cell 
block of the two cases were also negative for D5F3 immunostaining (score 0). Both false 
negative cases showed borderline cellularity (approximately 200 tumor cells) and 
relatively low percentage of tumor cells with ALK rearrangements on FISH test (20% 
and 22%).  
Thirty-nine of 40 FISH negative cases (97.5%) were negative on ALK ICC staining.  All 
39 ICC negative cases showed no staining (score 0). One FISH negative case showed 
strong ICC staining (score 3+) on the cell transferred smear (Figure 3) and the section cut 
from the cell block also demonstrating 3+ expression for D5F3 immunostaining. ALK 
FISH test of this case showed 0% tumor cells with ALK rearrangements and no sign of 
ALK gene copy number gain due to polysomy or amplification. 
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The negative predictive value of ALK ICC is 95%. The overall correlation between ALK 
ICC and FISH was 93.6%.  
Discussion 
Our study shows that the overall correlation between ALK FISH and ALK ICC using CT 
technique is fairly strong (93.6%) and the negative predictive value of ALK ICC is high 
(95%). ALK rearrangement is a rare phenomenon in lung cancers, with a reported 
incidence rate of only about 3-5%. As a result, the majority of samples received for ALK 
rearrangement testing will be negative. The high negative predictive value of ALK ICC 
makes it particularly useful for ALK rearrangement detection, since it may be used to 
screen out the majority of the negative samples at a relatively high confidence level. The 
negative result by ALK ICC is even more reliable when other mutations such as EGFR 
mutations are identified in the same sample, since ALK rearrangements are almost 
mutually exclusive with other mutations.  
Although ALK ICC has a fairly high negative predictive value, false negatives do exist. 
Two of 41 (5%) ALK ICC negative cases were tested positive using FISH on concurrent 
biopsy tissue or CB. Both those cases had low percentage (20% and 22%) of tumor cells 
with ALK rearrangements on FISH test, which may count for a possible cause of false 
negative. According to the manufacturer’s recommendation, 15% or more tumor cells 
with split signals are considered positive on ALK FISH assays. The actual percentage of 
tumor cells with ALK rearrangements is usually not reported. A recent study by Ilie et 
al14 compared the FISH and IHC results on resected lung adenocarcinoma, and found that 
all 5 discordant cases with FISH+/IHC- profile had low percentage of ALK+ tumor cells 
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on FISH (15-20%). It is conceivable that tumors with low percentage of ALK+ tumor 
cells on FISH would express ALK protein at a lower level and/or in a more focal 
distribution, compared to those with high percentage of ALK+ tumor cells. Focal or weak 
expression of ALK protein may not be detected due to the limited cellularity of the 
transferred cytology smears. Both of our two false negative cases had low to borderline 
cellularity on cell-transferred smears. Choosing more cellular smears would likely reduce 
or eliminate false-negative results in these cases; however, it is not always feasible. In our 
own practice, if the CB and the direct smears are both inadequate in cellularity, a repeat 
sampling is recommended.  
Another possible explanation of the false negative result is rare ALK translocations that 
do not result in ALK protein overexpression, or result in protein expression that is not 
recognized by this antibody clone. The study by Ilie et al14 showed that all five 
FISH+/IHC- cases did not contain the most frequent EML4-ALK fusion transcripts as 
revealed by RT-PCR analysis. 
The false negative results were not likely due to loss of antigenicity during the CT 
procedure, since results of ICC performed on cell-transferred cytology smear have shown 
high levels of agreement (97.5%) with those of corresponding FFPE tissues in our 
previous study12. 
One case with strong staining on ICC was negative for ALK rearrangements by FISH on 
concurrent CB, and IHC for ALK (D5F3) performed on the same CB also demonstrated 
3+ staining. Previous studies also reported rare cases in which ALK positivity by IHC 
was not reproduced by FISH. False-negative results of FISH may happen due to technical 
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difficulties in the interpretation of results. For example, the splitting of the red and green 
signals can be extremely subtle, especially in interphase chromatin since the splitting of 
signals is a consequence of a paracentric inversion on the same chromosomal arm and the 
splitting signals are only about 12Mb apart. The percentage of ALK+ tumor cells can be 
underestimated due to admixed normal cells. Another possible explanation is ALK 
protein overexpression caused by unknown types of ALK rearrangements or by events 
other than ALK rearrangements. ALK gene copy number gain due to polysomy has been 
reported to cause ALK protein overexpression detected by IHC14, although the false-
positive case in our current study did not have evidence of ALK gene copy number gain 
on FISH test.  Some authors reported significant clinical improvement with crizotinib in 
patients with tumors that were ALK-negative by FISH but were found to be ALK-
positive by IHC15.  
Our results are in agreement with those of previous studies using ICC to detect ALK on 
direct smears. Savic et al16 tested ALK ICC staining using the same clone (D5F3) on 41 
Papanicolau-stained cytology slides after decolorization and found a high concordance 
rate when compared with FISH results. Another smaller scale study on 18 cases by 
Tanaka et al17 showed high concordance rate between ALK ICC performed on destained 
direct smears and IHC performed on correlating FFPE tissue. Our study is different from 
these previous studies in that CT technique is used prior to ICC. CT technique has several 
advantages. The transferred smear can be divided into several parts so that multiple 
immunostains as well as multiple molecular tests can be performed from a single cellular 
smear. This is particularly important in the frequent situation when only a few cellular 
smears are available, but there is need to perform other diagnostic immunostains, such as 
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TTF-1 to rule out metastatic adenocarcinoma from other primary sites. At our institution, 
we routinely perform EGFR, KRAS molecular testing and ALK ICC on the same cellular 
smear. For these patients, using the CT technique reduces the need for repeat FNAs, 
thereby reducing potential patient morbidity and health care costs. Technically, CT is 
simple to perform and can be easily learned by a cytotechnologist or histotechnologist. 
There is no requirement for special equipment to perform this technique and the cost is 
relatively low. The only disadvantage of CT technique is that at least 5 hours of manual 
preparation is required to perform this technique, and this usually results in delaying the 
case for another day. 
Although there have been evidences that ALK IHC can be used as a screening test for 
FISH test, we don’t have enough evidence for using ALK ICC on cell-transferred smear 
as a screening test. In our current practice, ALK FISH test performed on tissue or CB is 
still the first choice for detecting ALK rearrangements. ALK ICC is performed only when 
the CB lacks adequate cellularity. Clinicians are informed of the possibility of a false 
negative ALK ICC test. Decisions of whether or not to repeat biopsy are made 
incorporating the ALK ICC result with other factors such as age, gender, smoking 
history, and EGFR/KRAS mutation status.  
The major limitation of current study is the relatively small sample size, especially the 
small number of FISH positive cases (n=7). Common limitations of a retrospective study, 
such as selection bias and information errors, also exist. A prospective study with a large 
number of cases is needed for further characterization of the test. 
In conclusion, our study showed that ICC performed on the FNA smears using the CT 
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technique is an alternative method for assessment of ALK rearrangement especially when 
the direct smears are highly cellular and the CB lacks adequate cellularity.  
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Table 1. Scoring system for ALK by ICC. 
Score Staining pattern ALK status 
0 No staining Negative 
1+ Faint, focal cytoplasmic staining in less than 50% of tumor cells Negative 
2+ Moderate, granular cytoplasmic staining (also can partly present 
strong staining) in more than 50% of tumor cells 
Positive 
3+ Strong, granular cytoplasmic staining in more than 75% tumor 
cells, diffusely homogeneity in distribution. 
Positive 
 
 
Table 2. Comparison between the results of ALK ICC and ALK FISH. 
ALK ICC ALK FISH positive ALK FISH negative Total 
Positive (2+/3+) 5 (10.6%) 1 (2.1%) 6 (12.8%) 
Negative (0/1+) 2 (4.3%) 39 (83.0%) 41 (87.2%) 
Total 7 (14.9%) 40 (85.1%) 47 (100%) 
Abbreviations: ALK, anaplastic lymphoma kinase; FISH, fluorescence in situ 
hybridization; ICC, immunocytochemistry. 
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Figure Legends 
Figure 1. Representative images of cases that were positive on ALK ICC and FISH. A) 
Papanicolaou-stained direct smears before CT. B) ALK ICC staining using D5F3 
antibody.  Original magnification: 400X.  
Figure 2. Representative images of cases that were ALK ICC negative but FISH positive. 
A) Papanicolaou-stained direct smears before CT. B) ALK ICC staining using D5F3 
antibody.  Original magnification: 400X. 
Figure 3. Representative images of the case that was ALK ICC positive but FISH 
negative. A) Papanicolaou-stained direct smears before CT. B) ALK ICC staining using 
D5F3 antibody.  Original magnification: 400X.  
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